Chester A. Mathis

58.9k total citations · 18 hit papers
356 papers, 32.2k citations indexed

About

Chester A. Mathis is a scholar working on Physiology, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Chester A. Mathis has authored 356 papers receiving a total of 32.2k indexed citations (citations by other indexed papers that have themselves been cited), including 154 papers in Physiology, 135 papers in Psychiatry and Mental health and 99 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Chester A. Mathis's work include Alzheimer's disease research and treatments (147 papers), Dementia and Cognitive Impairment Research (129 papers) and Medical Imaging Techniques and Applications (62 papers). Chester A. Mathis is often cited by papers focused on Alzheimer's disease research and treatments (147 papers), Dementia and Cognitive Impairment Research (129 papers) and Medical Imaging Techniques and Applications (62 papers). Chester A. Mathis collaborates with scholars based in United States, United Kingdom and Germany. Chester A. Mathis's co-authors include William E. Klunk, Julie C. Price, Steven T. DeKosky, Brian J. Lopresti, Daniel P. Holt, Manik L. Debnath, Mark A. Mintun, William J. Jagust, Guo-Feng Huang and Gina LaRossa and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

In The Last Decade

Chester A. Mathis

350 papers receiving 31.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory

2005 1.6k citations William E. Klunk, Chester A. Mathis et al. profile →
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ ₄₂ in humans

2005 960 citations Robert H. Mach, William E. Klunk et al. profile →
[ ¹¹ C]PIB in a nondemented population

2006 833 citations Robert H. Mach, William E. Klunk et al. Neurology profile →
Synthesis and Evaluation of ¹¹C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents

2003 828 citations Chester A. Mathis, Daniel P. Holt et al. profile →
Imaging β-amyloid burden in aging and dementia

2007 813 citations William E. Klunk, Chester A. Mathis et al. Neurology profile →
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

2008 799 citations Howard Aizenstein, Julie C. Price et al. profile →
11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

2008 758 citations William E. Klunk, Chester A. Mathis et al. profile →
The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

2014 690 citations William E. Klunk, Julie C. Price et al. profile →
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

2008 681 citations Miloš D. Ikonomović, William E. Klunk et al. profile →
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

2011 638 citations Victor L. Villemagne, Pierrick Bourgeat et al. profile →
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

2009 618 citations Eric M. Reiman, Kewei Chen et al. Proceedings of the National Academy of Sciences profile →
-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease

2007 616 citations Chester A. Mathis, William E. Klunk et al. profile →
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

2008 546 citations Chester A. Mathis et al. profile →
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B

2005 544 citations Julie C. Price, William E. Klunk et al. profile →
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

2010 536 citations William E. Klunk, Chester A. Mathis et al. profile →
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria

2001 522 citations Wayne C. Drevets, Julie C. Price et al. profile →
Pet imaging of serotonin 1A receptor binding in depression

1999 503 citations Wayne C. Drevets, Julie C. Price et al. profile →
Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

2015 450 citations William E. Klunk, Chester A. Mathis et al. profile →

Peers

Countries citing papers authored by Chester A. Mathis

Since Specialization

Citations

This map shows the geographic impact of Chester A. Mathis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chester A. Mathis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chester A. Mathis more than expected).

Fields of papers citing papers by Chester A. Mathis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chester A. Mathis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chester A. Mathis. The network helps show where Chester A. Mathis may publish in the future.

Co-authorship network of co-authors of Chester A. Mathis

This figure shows the co-authorship network connecting the top 25 collaborators of Chester A. Mathis. A scholar is included among the top collaborators of Chester A. Mathis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chester A. Mathis. Chester A. Mathis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of N-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography 2025 ·Cells ·Haiyang Zhao, Tianyu Huang, Dhruva D. Dhavale, (unknown), Zsofia Lengyel‐Zhand, (unknown), Jiwei Gu, Xuyi Yue, Ying‐Hwey Nai, Hao Jiang, (unknown), Vinayak Vishnu Pagar, Hee Jong Kim, Benjamin A. García, E. James Petersson, Chester A. Mathis, Paul T. Kotzbauer, Joel S. Perlmutter, Robert H. Mach, (unknown)	0
2	Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies 2024 ·Nature Communications ·(unknown), (unknown), Junchao Tong, N. Scott Mason, Daniel Sohn, Johan Sandell, Peter Ström, Jeffrey S. Stehouwer, Brian J. Lopresti, Jenny Viklund, Samuel Svensson, Chester A. Mathis, Neil Vasdev	19
3	Development of Pyridothiophene Compounds for PET Imaging of α‐Synuclein 2024 ·Chemistry - A European Journal ·Anna Pees, Junchao Tong, (unknown), (unknown), Steven H. Liang, (unknown), Robert H. Mach, Chester A. Mathis, Neil Vasdev	9
4	Biostatistical Estimation of Tau Threshold Hallmarks (BETTH) Algorithm for Human Tau PET Imaging Studies 2023 ·Journal of Nuclear Medicine ·Alexandra Gogola, Brian J. Lopresti, Dana Tudorascu, Beth E. Snitz, Davneet Minhas, Vincent Doré, Miloš D. Ikonomović, C. Elizabeth Shaaban, (unknown), Pierrick Bourgeat, N. Scott Mason, Howard Aizenstein, Chester A. Mathis, William E. Klunk, Christopher C. Rowe, Oscar L. López, Ann D. Cohen, Victor L. Villemagne, (unknown)	8
5	Radiosynthesis, In Vitro and In Vivo Evaluation of [¹⁸F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies 2021 ·ACS Chemical Neuroscience ·(unknown), Ashley C. Knight, Daniel Sohn, (unknown), Junchao Tong, (unknown), N. Scott Mason, Jeffrey S. Stehouwer, Brian J. Lopresti, William E. Klunk, Johan Sandell, (unknown), Per Hammarström, Samuel Svensson, Chester A. Mathis, Neil Vasdev	36
6	Relationship of amyloid beta and neurofibrillary tau deposition in Neurodegeneration in Aging Down Syndrome (NiAD) study at baseline 2020 ·Alzheimer s & Dementia Translational Research & Clinical Interventions ·(unknown), (unknown), Matthew Zammit, Davneet Minhas, (unknown), Paul A. Ellison, Shahid Zaman, Beau M. Ances, Marwan N. Sabbagh, (unknown), Chester A. Mathis, William E. Klunk, (unknown), (unknown), Ann D. Cohen	23
7	Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging 2018 ·Digital Commons@Becker (Washington University School of Medicine) ·Qi Yan, Kwangsik Nho, Jorge L. Del‐Aguila, Xingbin Wang, Shannon L. Risacher, Kang-Hsien Fan, Beth E. Snitz, Howard Aizenstein, Chester A. Mathis, Oscar L. López, F. Yesim Demirci, Eleanor Feingold, William E. Klunk, Andrew J. Saykin, Carlos Cruchaga, M. Ilyas Kamboh	1
8	Comparison of longitudinal Aβ in nondemented elderly and Down syndrome 2018 ·Neurobiology of Aging ·Dana Tudorascu, Stewart Anderson, Davneet Minhas, (unknown), Diane Comer, Patrick J. Lao, Sigan L. Hartley, Charles M. Laymon, Beth E. Snitz, Brian J. Lopresti, Sterling C. Johnson, Julie C. Price, Chester A. Mathis, Howard Aizenstein, William E. Klunk, Benjamin L. Handen, Brad T. Christian, Ann D. Cohen	12
9	Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [ ¹¹ C]PiB 2010 ·Neurology ·Susan M. Resnick, Jitka Sojkova, Zhou Yu, Youzhong An, (unknown), Daniel P. Holt, Robert F. Dannals, Chester A. Mathis, William E. Klunk, Luigi Ferrucci, Michael A. Kraut, Dean F. Wong	212
10	Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease breakdown → 2009 ·Proceedings of the National Academy of Sciences ·Eric M. Reiman, Kewei Chen, Xiaofen Liu, Daniel Bandy, Meixiang Yu, Wendy Lee, Napatkamon Ayutyanont, Jennifer Keppler, Stephanie Reeder, Jessica B. Langbaum, Gene E. Alexander, William E. Klunk, Chester A. Mathis, Julie C. Price, Howard Aizenstein, Steven T. DeKosky, Richard J. Caselli	618
11	Imaging Alzheimer Pathology in Late-Life Depression With PET and Pittsburgh Compound-B 2008 ·Alzheimer Disease & Associated Disorders ·Meryl A. Butters, William E. Klunk, Chester A. Mathis, Julie C. Price, Scott K. Ziolko, Jessica A. Hoge, Nicholas D. Tsopelas, Brian J. Lopresti, Charles F. Reynolds, Steven T. DeKosky, Carolyn C. Meltzer	107
12	Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern? 2008 ·Journal of Nuclear Medicine ·Jitka Sojkova, Lori L. Beason‐Held, Yun Zhou, Yang An, Michael A. Kraut, (unknown), Luigi Ferrucci, Chester A. Mathis, William E. Klunk, Dean F. Wong, Susan M. Resnick	59
13	X‐34 Labeling of Abnormal Protein Aggregates During the Progression of Alzheimer's Disease 2006 ·Methods in enzymology on CD-ROM/Methods in enzymology ·Miloš D. Ikonomović, Eric E. Abrahamson, Barbara A. Isanski, Manik L. Debnath, Chester A. Mathis, Steven T. DeKosky, William E. Klunk	45
14	Anti-Aβ antibody treatment promotes the rapid recovery of amyloid-associated neuritic dystrophy in PDAPP transgenic mice 2005 ·Journal of Clinical Investigation ·Robert P. Brendza, Brian J. Bacskai, John R. Cirrito, Kelly Simmons, Jesse Skoch, William E. Klunk, Chester A. Mathis, Kelly R. Bales, Steven M. Paul, Bradley T. Hyman, David M. Holtzman	23
15	PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS 2004 ·Journal of Clinical Investigation ·Sriram Venneti, Brian J. Lopresti, Guoji Wang, Stephanie J. Bissel, Chester A. Mathis, Carolyn C. Meltzer, Fernando E. Boada, Saverio Capuano, Geraldine J. Kress, Denise Davis, (unknown), Ian J. Reynolds, Michael Murphey‐Corb, Anita M. Trichel, Stephen R. Wisniewski, Clayton A. Wiley	42
16	Gender-specific aging reductions in [11C-carbonyl] WAY100635 binding: Not an effect of atrophy 2000 ·NeuroImage ·Carolyn C. Meltzer, Wayne C. Drevets, Julie C. Price, Chester A. Mathis, Brian J. Lopresti, Phil J. Greer, Victor L. Villemagne, Daniel P. Holt, N. Scott Mason, Charles F. Reynolds, Steven T. DeKosky	1
17	Interhemispheric modulation of dopamine receptor interactions in unilateral 6‐OHDA rodent model 1995 ·Synapse ·Cindy P. Lawler, John H. Gilmore, Val J. Watts, Q. David Walker, (unknown), Larry L. Cook, Chester A. Mathis, Richard B. Mailman	22
18	Synthesis of aryl-substituted 5-[18F]fluoroalkylbenzamides: High affinity ligands for dopamine D-2 studies 1991 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Chester A. Mathis, John E. Bishop, John M. Gerdes, (unknown), Richard B. Mailman	2
19	Synthesis and evaluation of (S)-5-[125I]iodo-2,3-methylenedioxybenzamide 1991 ·Journal of Labelled Compounds and Radiopharmaceuticals ·Chester A. Mathis, John M. Gerdes, Alexander T. Shulgin, Stephen M. Hanrahan, (unknown), Richard B. Mailman	1
20	Unification of idempotent functions 1977 ·International Joint Conference on Artificial Intelligence ·(unknown), Chester A. Mathis, (unknown), (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact